NCT06916949

Brief Summary

The goal of this interventional study is to collect clinical and neurophysiological information to determine whether high-fidelity simulation can serve as a stress-inducing stimulus in a population of healthy residents (Emergency medicine, Anesthesia and Intensive care medicine, Paediatrics), both male and female, aged between 25 and 40 years. The main questions it aims to answer are:

  • During the simulation, automatic pupillometry will be performed on all team members at the four time points.
  • Additionally, a two-lead ECG will be recorded for all team members at baseline and end of the debriefing
  • One team member will undergo EEG monitoring throughout the entire simulation. The EEG recordings will be sampled at baseline, during the simulation and end of the debriefing.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 8, 2025

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

April 8, 2025

Status Verified

January 1, 2025

Enrollment Period

Same day

First QC Date

February 11, 2025

Last Update Submit

April 1, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Heart Rate Variability (HRV) Analysis in the time domain

    To assess whether stress levels vary during simulation phases. All subjects will undergo electrocardiographic (ECG) recording at baseline and at the end of the debriefing using a portable Holter ECG device. The ECG traces will then be extracted, artifact-cleaned, and converted for Heart Rate Variability (HRV) analysis using dedicated software. HRV is a measure of the variation in R-R intervals between consecutive heartbeats and reflects the extrinsic regulation of heart rate mediated by the autonomic nervous system on the sinoatrial node.

    From the enrolment to two weeks after

  • Heart rate variability (HRV) analysis in the frequency domain

    Low frequency (LF) reflects the simultaneous influence of both sympathetic and parasympathetic control on the sinoatrial node; and high frequency (HF) reflects parasympathetic nervous system modulation. The LF/HF ratio will be calculated as an indicator of the sympathovagal balance.

    from the enrolment to two weeks after

Secondary Outcomes (3)

  • Changes in autonomic parameters in response to stress induced by high-fidelity simulation: automatic pupillometry.

    From the enrolment to two weeks after

  • Identify brain areas involved during simulation using EEG

    From the enrolment to two weeks after

  • Variation of stress level over time using Perceived Stress Scale 10

    From the enrolment to two weeks after

Study Arms (1)

Simulation team

EXPERIMENTAL

All participants will be divided in teams, each one consisting of three medical trainees from the same specialty training program, and all of them will undergo two high-fidelity simulations based on a clinical scenario relevant to their specialization.

Diagnostic Test: ElectrocardiogramDiagnostic Test: PupillometryDiagnostic Test: Electroencephalogram

Interventions

ElectrocardiogramDIAGNOSTIC_TEST

two leads ECG

Also known as: ECG, EKG
Simulation team
PupillometryDIAGNOSTIC_TEST

During the simulation, automatic pupillometry will be performed on all team members at the following time points: Baseline (T0) During the simulation (T1) End of the simulation (T2) End of the debriefing (T3)

Simulation team
ElectroencephalogramDIAGNOSTIC_TEST

EEG monitoring throughout the entire simulation. The EEG recordings will be sampled at: Baseline (T0) During the simulation (T1) End of the debriefing (T2)

Also known as: EEG
Simulation team

Eligibility Criteria

Age25 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Medical trainees from the specialties of Emergency Medicine, Anesthesia and Intensive Care, Clinical Toxicology, Pediatrics, and Neonatology.
  • Normal hearing and vision, or corrected to normal.

You may not qualify if:

  • Known history of psychiatric disorders, cognitive impairment, or cardiac arrhythmias.
  • Current treatment with psychoactive, cardio-stimulant, or cardio-inhibitory medications.
  • Significant stressful life events in the past six months (e.g., family bereavement).
  • Previous systematic experience in meditation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Champeroux P, Fesler P, Jude S, Richard S, Le Guennec JY, Thireau J. High-frequency autonomic modulation: a new model for analysis of autonomic cardiac control. Br J Pharmacol. 2018 Aug;175(15):3131-3143. doi: 10.1111/bph.14354. Epub 2018 Jun 15.

    PMID: 29723392BACKGROUND
  • Niskanen JP, Tarvainen MP, Ranta-Aho PO, Karjalainen PA. Software for advanced HRV analysis. Comput Methods Programs Biomed. 2004 Oct;76(1):73-81. doi: 10.1016/j.cmpb.2004.03.004.

    PMID: 15313543BACKGROUND

MeSH Terms

Interventions

ElectrocardiographyElectroencephalography

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisDiagnostic Techniques, Neurological

Study Officials

  • Antonio Gullì

    Fondazione Policlinico Universitario A. Gemelli, IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2025

First Posted

April 8, 2025

Study Start

April 1, 2025

Primary Completion

April 1, 2025

Study Completion

May 1, 2025

Last Updated

April 8, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

All IPD collected throughout the trial

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Beginning 3 months and ending 3 years after the publication of results
Access Criteria
All researchers that wish to, can gain access to the IPD and supporting information by contacting the corresponding author